Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung ultrasound may Fine-Tune fluid removal in dialysis patients

NCT ID NCT05132036

Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a simple lung ultrasound can accurately detect fluid overload in people on hemodialysis. 46 patients had an ultrasound before their regular dialysis session, and the results were compared to other standard tests. The goal is to help doctors better determine how much fluid to remove during dialysis, which could improve heart health and reduce complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a simpler, non-invasive way to guide fluid removal during dialysis, potentially improving heart health and reducing complications.
What could go wrong
This is a small, completed observational study, not a treatment trial. The ultrasound method needs further validation in larger, more diverse groups before it can replace current practices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Nov 2021

Finished

Jun 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age over 18 years old * patients on hemodialysis for more than 3 months; * patients without cardiological or infectious event for at least 3 months; * patients having at least 2 dialysis session per week; * patients affiliated with a health insurance plan; * patients having signed an informed consent. Exclusion Criteria: * Pulmonary fibrosis or active lung disease; * residual diuresis over 500 mL per day; * body mass index (BMI) \< 21 and \> 28 Kg/m²; * medical history of major amputation (subgonal or transfemoral); * pacemaker carrier; * patients with orthopedic prosthesis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemodialysis complication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dialysis disequilibrium syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemodialysis complication Lung ultrasound

Contacts and locations

Locations

  • CHU Amiens

    Amiens, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.